4.4 Article

Fluctuation of Viremia in Hepatitis B Virus-Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 37, Issue 6, Pages 655-660

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/ice.2016.49

Keywords

-

Ask authors/readers for more resources

OBJECTIVE. To determine the longitudinal changes in viral load of hepatitis B virus (HBV)-infected healthcare workers (HCWs) and its consequences for exclusion of infected HCWs performing exposure-prone procedures, various HBV DNA safety thresholds, and the frequency of monitoring. DESIGN. Retrospective cohort study June 1, 1996-January 31, 2013. PARTICIPANTS. In the Netherlands, chronically HBV-infected HCWs performing exposure-prone procedures are notified to the Committee for Prevention of Iatrogenic Hepatitis B. Of the 126 notified HCWs, 45 had 2 or more HBV DNA levels determined without antiviral therapy. METHODS. A time-to-event analysis for HBV-infected HCWs categorized in various viremia levels surpassing a HBV DNA threshold level of 1x10(5) copies/mL, above which exposure-prone procedures are not allowed in the Netherlands. RESULTS. Fluctuations of HBV DNA in follow-up samples ranged from -5.4 to +2.2 log(10) copies/mL. A high correlation was seen for each HBV DNA level with the 3 previous levels. In a time-to-event analysis, after 6 months 7.2%, 6.5%, and 14.3% of individuals had surpassed the threshold of 1 x 10(5) copies/mL for viral load categories 4.8 x 10(3) to 1.5 x 10(4); 1.5 x 10(4) to 4.0 x 10(4); and 4.0 x 10(4) to 1.0 x 10(5), respectively. CONCLUSIONS. We propose standard retesting every 6 months, with more frequent retesting just below the high threshold value (1x10(5) copies/mL), and prolonging this standard interval to 1 year after 3 consecutive levels below the threshold in policies with lower safety thresholds (1x10(3) or 1x10(4) copies/mL).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program

Stijn Raven, Jeannine Hautvast, Jim van Steenbergen, Reinier Akkermans, Cas Weykamp, Francis Smits, Christian Hoebe, Ann Vossen

JOURNAL OF CLINICAL VIROLOGY (2017)

Article Public, Environmental & Occupational Health

Solitary IgM phase II response has a limited predictive value in the diagnosis of acute Q fever

C. F. H. Raven, J. L. A. Hautvast, T. Herremans, A. C. A. P. Leenders, P. M. Schneeberger

EPIDEMIOLOGY AND INFECTION (2012)

Article Immunology

Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination

Stijn Raven, Anouk Urbanus, Anouk de Gee, Christian Hoebe, Jim van Steenbergen

VACCINE (2018)

Article Infectious Diseases

Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial

Stijn F. H. Raven, Christian J. P. A. Hoebe, Ann C. T. M. Vossen, Leo G. Visser, Jeannine L. A. Hautvast, Anna H. E. Roukens, Jim E. van Steenbergen

LANCET INFECTIOUS DISEASES (2020)

Letter Immunology

Only one serological assessment is sufficient to determine the need for hepatitis B revaccination in non-responders

Stijn F. H. Raven, Jeannine L. A. Hautvast, Christian J. P. A. Hoebe

VACCINE (2020)

Article Infectious Diseases

First autochthonous human West Nile virus infections in the Netherlands, July to August 2020

Danique R. M. Vlaskamp, Steven F. T. Thijsen, Johan Reimerink, Pieter Hilkens, Willem H. Bouvy, Sabine E. Bantjes, Bart J. M. Vlaminckx, Hans Zaaijer, Hans H. T. C. van den Kerkhof, Stijn F. H. Raven, Chantal B. E. M. Reusken

EUROSURVEILLANCE (2020)

Article Immunology

Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders

Christian Beulens, Stijn F. H. Raven, Cornelia H. M. van Jaarsveld, Inge van Loo, Greet Boland, Leo G. Visser, Christian J. P. A. Hoebe, Ann C. T. M. Vossen

Summary: This study compared the performance of four anti-HBs assays in detecting low levels of antibodies in non-responders after primary hepatitis B vaccination. A strategy guided by anti-HBs titres was proposed for revaccination. The results showed that all assays demonstrated a comparable difference in seroconversion rate between zero- and poor-responders after one revaccination dose. A titre-based strategy reduced the amount of revaccinations compared with the standard three-dose series.

VACCINE (2022)

Article Infectious Diseases

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021

Catharina E. van Ewijk, Marjolein N. Kooijman, Ewout Fanoy, Stijn F. H. Raven, Marit Middeldorp, Anita Shah, Brechje de Gier, Hester E. de Melker, Susan J. M. Hahne, Mirjam J. Knol

Summary: This study aimed to determine the effectiveness of SARS-CoV-2 vaccines against infection and found that exposure did not significantly confound the estimated effectiveness, suggesting that vaccine effectiveness can be accurately estimated using routine data.

EUROSURVEILLANCE (2022)

Article Virology

Integrated surveillance of human respiratory viruses in addition to SARS-CoV-2 in a public testing facility in the Netherlands

N. L. Plantinga, M. C. J. van Lanschot, C. F. H. Raven, R. Schuurman, A. F. Rirash, B. van Deursen, G. J. Boland, T. O. Siksma, E. Fries, M. Mostert, S. F. T. Thijsen, L. M. Hofstra

Summary: This study evaluated integrated community surveillance of SARS-CoV-2 and other respiratory viruses and described epidemiological trends. The findings showed that integrated respiratory viral surveillance within public testing facilities is feasible and informative. The prevalence of respiratory symptoms and detection of SARS-CoV-2 and other respiratory viruses varied over time. Integrated surveillance can help inform policymakers and hospitals for appropriate response measures during respiratory seasons.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Infectious Diseases

Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008-2016)

Stijn Raven, Jeannine Hautvast, Wing-Kee Yiek, Irene Veldhuijzen, Jim van Steenbergen, Fleur van Aar, Christian J. P. A. Hoebe

Summary: Sexual health centres play an important role in case finding of chronic hepatitis B (CHB) in the Netherlands. These centres should be considered as important settings for screening high-risk groups, such as men who have sex with men (MSM), commercial sex workers (CSWs), and first-generation migrants (FGMs), in order to reduce the burden of HBV-related diseases.

SEXUALLY TRANSMITTED INFECTIONS (2023)

Article Immunology

Time Scales of Human Mpox Transmission in The Netherlands

Fuminari Miura, Jantien A. Backer, Gini van Rijckevorsel, Roisin Bavalia, Stijn Raven, Mariska Petrignani, Kylie E. C. Ainslie, Jacco Wallinga

Summary: Exposure histories of 109 pairs of mpox cases in the Netherlands were investigated, and 34 pairs were identified where transmission was likely and the infectee reported a single potential infector with a mean serial interval of 10.1 days. Mpox has spread rapidly to many countries in nonendemic regions. These findings emphasize the importance of precaution regardless of recognizable symptoms of mpox.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic

Lisanne Heijmink, Juul Tonis, Niek Gilhuis, Maartje Gerkema, Lotte Hart, Stijn Raven, Jossy van den Boogaard, Agnetha Hofhuis, Susan van den Hof, Olga Visser

Summary: A study in Utrecht, the Netherlands, found that mass testing can significantly increase test incidence and provide a more complete view of the presence of SARS-CoV-2. However, the proportionality of its overall gain remains uncertain.

EPIDEMIOLOGY AND INFECTION (2022)

No Data Available